ClinicalTrials.gg
Biological

Vero cell line clinical trials

studies test it
6
open now
0
in phase 3
2
first study started
2021

How each study uses vero cell line is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

SARS-CoV-2 Vaccine (Vero Cells), Inactivated
3

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
3
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 0

Shenzhen Kangtai Biological Products Co., LTD (3) · National Vaccine and Serum Institute, China (2) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1)

Often tested with

Tested in the same studies.

CHO cell (1)

Studies

Open first, then newest update. How each study uses vero cell line is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6

Given beside what is tested · 2 — vero cell line is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with vero cell line